Medical device manufacturers face a projected 50% surge in global plastic use by 2040, forcing the industry to confront deep vulnerabilities in its reliance on virgin fossil fuel-derived polymers, Contract Pharma reported. Complex international supply chains delivering these materials have suffered repeated disruptions from geopolitical instability, cyberattacks, and the pandemic, turning raw material dependency into a significant long-term business risk.
Bio-based polymers cost more than fossil fuels
Alternative bio-based polymers offer a potential path forward, yet they typically cost 50% to 100% more than fossil fuel-based plastics due to fluctuating feedstock prices and smaller production scales. According to European Bioplastics, global production capacity for bio-based plastics currently sits at approximately 0.5% of total annual plastic output.
Circular design strategies reduce reliance on plastics
Rather than relying solely on material substitution, circular design engineering focuses on lower material demand, extended use, and high-value recovery. In a June 2025 Lancet comment published online at https://doi.org/10.1016/S0140-6736(25)01099-2, researchers Alice Street, Anne Kveim Lie, Bruno J. Strasser, and Jeremy A. Greene emphasized that current disposable practices in health care are not inevitable, noting that integrating engineering with social sciences can redesign materials and systems to reduce reliance on harmful plastics.
Device remanufacturing generates millions in hospital savings
While recycling turns complex devices into low-value pellets and loses precision molding value, medical device reprocessing and remanufacturing restore technical and functional safety. Figures provided by the Association of Medical Device Reprocessors show that during 2025 alone, 11,458 surgical centers and hospitals across 18 nations purchased upwards of 39.3 million regulated and reprocessed single-use devices. This practice reduced CO2-equivalent emissions by over 125 million pounds and generated more than $449.5 million in hospital savings.
Frequently Asked Questions on Medical Plastics
Why can medical device manufacturers not easily switch to alternative plastics?
Medical materials require strict validation for biocompatibility, safety, and regulatory compliance.
How much more expensive are bio-based polymers compared to conventional plastics?
Bio-based polymers typically cost between 50% and 100% more to produce than fossil fuel-based plastics. This price premium stems from volatile feedstock crop costs and limited industrial production scales.
What scale did medical device reprocessing reach recently?
During 2025, a total of 11,458 surgical facilities and hospitals spanning 18 nations purchased more than 39.3 million regulated, reprocessed single-use devices, according to figures released by the Association of Medical Device Reprocessors.